Stock Chart

ASMB

$26.98 -4.46%
Score: 55.2 HOLD
LEAPs: SELL $40
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $40
Premium: $8.50
Expiry: Jun 18, 2026
Target: $40
Score: -95

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $21.06 - $28.34 UPTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.17
Vol: 1.05x (vs SPY: 1.0x | vs QQQ: 0.8x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About ASMB - Assembly Biosciences, Inc

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has …

Key Statistics

Market Cap $417M

This ASMB stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ASMB's price movements with trendlines, gamma walls, and key support/resistance levels.